Alibion was born to bring new drug discoveries out of academic labs and closer to patients. Hundreds of new therapies are developed each year by academic groups. Many of these new therapies will, regrettably, never start preclinical and clinical testing due a lack of sufficient early stage development partners. This creates an immense need and a great opportunity.
Alibion comes to close this gap. We accelerate the development of therapeutics through early stages. Our efforts are focused on identifying promising novel therapeutics and pooling the necessary resources to drive these compounds out of the labs and into late-stage development. We strive to improve patient outcomes worldwide by bringing innovative therapeutics closer to patients. Join us and together lets build a better, healthier future.
Thanks to the generous support of:
We will become leaders in the early-stage development of therapeutics. We will achieve continuity and growth with a replicable, standardized process.
c/o Switzerland Innovation Park Basel Area AG
Gewerbestrasse 24, 4123 Allschwil
Tel: +41 79 549 0242
For enquiries, leave us a message below